Vascular smooth muscle cells (SMCs) are present in several phenotypic states in blood vessels. They show a high degree of plasticity, undergoing rapid and reversible phenotypic changes in response to environmental stresses and vascular injury. Thereby, SMCs play an important role in development of atherosclerosis and restenosis after angioplasty and coronary bypass grafting. Many functions of SMCs, such as adhesion, migration, proliferation, contraction, differentiation and apoptosis are determined by surface adhesion receptors involved in cell-cell binding and interactions between cells and extracellular matrix (ECM) proteins. Some cell adhesion receptors are involved in intracellular signalling and participate in cellular response to different stimuli. The adhesion receptors of vascular SMCs discussed here include the ECM adhesion receptors integrins, a-dystroglycan and syndecans, as well as the cell-cell adhesion receptors cadherins and cell adhesion molecules. This review is intended to provide a generalised overview of the receptors expressed in vascular SMCs in relation to their functions and implications for vascular pathology.
Introduction
forces. In addition to integrins and syndecans, found in non-muscle cell types, contractile SMCs contain a muscle There is a considerable level of heterogeneity of vascuspecific dystrophin-glycoprotein complex (DGPC), linklar smooth muscle cells (SMCs) in blood vessels. Vascular ing actin filaments to ECM. The other important function SMCs exhibit distinct morphological and functional propof SMCs is related to the SMC response to environmental erties within the same blood vessel [1, 2] , as well as in stresses and the repair of the blood vessel wall after different types of blood vessels, e.g. arteries and veins [3] . vascular injury [1, 4] . These responses require modulation The principle function of vascular SMCs is to maintain of the SM phenotype, synthetic and migratory activities of vascular tone and resistance. The differentiated SMCs SMCs, which in turn need disengagement of adhesion exhibit a contractile phenotype, and express smooth musreceptors anchoring cells to ECM during cell contraction. cle (SM) specific contractile and cytoskeletal proteins [4] .
The dedifferentiated SMCs are motile and express an Adhesion of contractile SMCs to the extracellular matrix altered set of adhesion receptors. Therefore, modulation of (ECM) is fortified in order to withstand considerable SM phenotype is crucial in the development of many tensions due to SMC contraction and haemodynamic vascular diseases including atherosclerosis and restenosis after angioplasty and coronary artery bypass grafting. To date, the factors and the mechanisms involved in
Abbreviations: DGPC, dystrophin-glycoprotein complex; ECM, exregulation of SMC phenotype remain obscure. However, tracellular matrix; ECs, endothelial cells; IAP, integrin-associated protein; ICAM-1, intercellular cell adhesion molecule-1; PIP2, phosphatidylinothe ECM is likely to play a pivotal role in regulation of sitol (4,5)-biphosphate; PKC, protein kinase C; RGD, arginine-glycine-SMC phenotype [5, 6] . Vascular contractile SMCs are aspartic acid; SM, smooth muscle; SMCs, SM cells; uPAR, urokinaseembedded in the ECM and surrounded by an incomplete type plasminogen activator receptor, VCAM-1, vascular cell adhesion basement membrane in vivo [7, 8] and one of its essential components laminin, surrounding receptors to their functions in a specific SM phenotype contractile SMCs in the blood vessels [7, 9] , play an and / or a particular pathophysiological process. Fig. 1 important role in the differentiation of SMCs. The temposchematically shows some of the information presented ral phenotypic modulation of SMCs during vascular injury below. leads to the destruction of the basement membrane, which reappears when SMCs revert to the contractile phenotype [7] . Laminin is also implicated in maintaining the SMC 2. SMC integrins contractile phenotype in vitro [10] [11] [12] [13] [14] .
ECM adhesion receptors provide a link between the Integrin receptors are the principle receptors for the cytoskeleton and the ECM in cell-ECM contacts. ECM ECM and serve as a transmembrane link between the ECM adhesion receptors play a major role in SMC adhesion, and the actin cytoskeleton (Fig. 2) . Integrins are bound to although cell-cell adhesion receptors are also found in an intracellular protein complex, which includes the cytoSMCs. A vast number of studies has revealed a central role skeletal proteins talin, vinculin, a-actinin and filamin [ 
Integrin expression in vascular SM related to the SMC phenotype and interactions of SMCs with other cell types via integrins
Integrins expressed in vascular SM are shown in Table  1 . Integrins b1 are predominant in vascular SM in vivo and in cultured SMCs [26, 32] . They are present in the activated high affinity form in arteries [65] . Vascular injury reduces expression of total and activated b1 integrin in neointima [65] . Deactivation of b1 integrins correlates with increased proliferative and migratory activities of SMCs [65, 66] . Hence, expression of activated b1 integrins may contribute to maintaining the contractile SM phenotype.
The major a integrin subunits present in vascular SM in vivo are a1, a3 and a5 [26, 29] . Expression of a1b1 and types [45, 67] , therefore, it may influence expression of and a7b1 and the dystrophin-glycoprotein complex (DGPC) with aother integrins in contractile SMCs. Noteworthy, both dystroglycan. Integrins localise in the adherens junctions on longitudinal a1b1 and a7b1 bind to laminin, which is involved in ribs of cells (shown in black) (after [128] vessels, where it co-localises with its ligand cellular fibronectin and a counter-receptor vascular cell adhesion may mediate interactions between SMCs and VCAM-1-molecule-1 (VCAM-1) [37, 38] . This integrin binds to an expressing ECs. additional site of fibronectin, encoded by an alternatively
Integrins av are expressed in the blood vessel wall, spliced exon. Expression of a4b1 integrin and VCAM-1 is although they are not the major integrins. Expression of a prerequisite for expression of SM phenotype markers in avb3 integrin varies dramatically in SMCs of different human cultured SMCs [38] . This integrin is also found in origin [57, 58] . Microscopic studies have shown co-localiatherosclerotic intimal thickening together with VCAM-1 sation of integrins avb3 and avb5 with their ligand (see below) and may be involved in cell-cell interactions vitronectin in the atherosclerotic intima [60] . Some ECM between SMCs and VCAM-1-expressing endothelial cells ligands for avb3, such as fibrin, fibrinogen, thrombospon-(ECs) [38] . Since another integrin, a9b1, also binds to din, vitronectin and osteopontin, are not detectable in VCAM-1 [54] and is expressed in vascular SM [55] , it normal blood vessels and found only in diseased blood [26] . Expressed in OSP [36] atherosclerotic intima, human embryonic newborn ductus arteriosus SMCs [33] aorta, but not adult aorta [26, 37, 38] a5 b1 FN; FN [22, 23] ; Found in the media of human normal and Abundant in SMCs [22, 26, 29, 32 ,33] tOSP [39] FB [33] atherosclerotic coronary artery, aorta and Modulated expression [34] other vascular SM [26, 28, 29, 40] . Not found in the rat normal carotid artery, its expression was induced after a vascular injury in SMCs at the lumenal surface of the neointima [41] a6 b1 / LN 1; LN 8 [42] LN 1 [43] Found in ductus arteriosus SM and in Not expressed [26, 33] . Expressed in b4 small vessels [28, 44] . Not expressed foetal ductus arteriosus SMCs [43] in aortic SM [26] a7 b1 LN 1; LN 2, LN 1 [22, 46] Expressed at high levels in vascular Expressed in foetal ductus arteriosus LN 4 [45] SM [47] . Only a7B isoform is SMCs [22] . Downregulated in expressed in SM [47] cultured aortic SMCs [47] a8 b1 FN, TN, VN, Predominantly expressed in SM [50] Expressed in aortic SMCs [30] not OSP [48] ; OSP [49] a9 b1 TN [51] ; tOSP [52, 53] ; Expressed in vascular SM [55] Not expressed in newborn VCAM-1 [54] ductus arteriosus SMCs [33] av b1 VN, FN; agrin [56] VN, FN [22] ; Expressed in foetal ductus OSP [57] arteriosus and other vascular SMCs [22, 57] [28, 60] Very early upregulated after injury [62] Data contradicting previous reports are shown in italics. Conflicting data have been reported on the expression of a1, a5 and avb3 integrins; these discrepancies are likely to be caused by differences in detection levels, variations between species or variable levels of integrin expression in SMCs from sources of different origin. Integrin specificity is indicated as presented before [16, 17] . Newly described and SM integrin ligands are presented with references. COL, collagen; dCOL, denatured COL; FB, fibrin; FG, fibrinogen; FN, fibronectin; LN, laminin, PLC, perlecan; OSP, osteopontin; TN, tenascin; tOSP; thrombin-cleaved OSP; TSP, thrombospondin; VN, vitronectin; vWF, von Willebrand factor. vessels [60, [69] [70] [71] [72] . Integrins avb3 and avb5 are upregu-2.3. Integrin signalling in cell adhesion, proliferation, lated early after vascular injury and are likely to be apoptosis and other SMC functions involved in postangioplasty events and neointima formation [62] .
Integrins participate in several signalling pathways. Integrin ligation and clustering in response to the ECM 2.2. Adhesion, migration, ECM assembly and ECM initiate an assembly of integrin-cytoskeleton complexes to contraction support cell adhesion. Several integrin-associated proteins, such as urokinase-type plasminogen activator receptor Integrins b1 are considered to play a major role in (uPAR), integrin-associated protein (IAP) and tetraspanin adhesion [22] , ECM assembly, repair and remodelling.
CD9, modulate integrin-mediated adhesion in SMCs. The Several SMC integrins bind to laminin, but only a7b1 uPAR associates with and stabilises b1 integrin-caveolin integrin has been shown to affect laminin adhesion in complexes in human SMCs; this association is required for SMCs [47] . Integrin a7b1 also plays an important role in b1 integrin-mediated SMC migration [88] [89] [90] . SMC milaminin polymerisation [73] . Among integrins a1b1, a2b1 gration to collagen is potentiated by thrombospondin via and a3b1, involved in collagen adhesion, only a1b1 and thrombospondin-binding IAP, which is associated with a2b1 are responsible for collagen contraction a2b1 integrin in SMCs [91, 92] . In human vascular SMCs, [23, 30, 31, 74] . Since only a1b1 is expressed in vivo, it is CD9 is mainly associated with a2b1, a3b1 and a5b1 likely to be involved in collagen remodelling after vascular integrins and affects collagen gel contraction [93] . injury.
Some integrins participate in another category of sigAdhesion to fibronectin is mediated by integrins a3b1 nalling leading to cell proliferation, differentiation and and a5b1 [23, 74] . Integrin a5b1, highly abundant in apoptosis (reviewed in [18, 19] ). Integrins also contribute to cultured SMCs, is also involved in fibronectin polymerithe cell response to growth factors. Integrin-mediated sation [41] . This has important implications for SMC signalling, which is related to these SMC functions, is proliferation, since inhibition of the fibronectin matrix summarised below. assembly inhibits proliferation of human primary SMCs
Integrins av affect many functions of SMCs in contrast [75] . After vascular injury, a5b1 is induced at the lumenal to other integrins. Integrin avb3 together with a5b1 21 surface of neointima and may be involved in blood vessel affects Ca influx in arteriolar SMCs, indicating the link 21 wall repair and incorporation of plasma fibronectin into through intracellular signalling pathways to the Ca ECM [41] . Recently this integrin has been implicated in channels [94, 95] . Blocking avb3 integrin causes a de- 21 fibrin adhesion and fibrin clot contraction [33] . Since fibrin crease in Ca influx in parallel to the arteriolar lumen is present in atherosclerotic plaques [69] and fibrinogen is diameter increase [94] . Therefore, the effect of avb3 abundant in the intima of atherosclerotic aorta [70] , a5b1 integrin on arteriolar vasodilation in response to tissue integrin is thought to cause vessel narrowing during the injury, observed earlier [96] , may be mediated by avb3 21 progression of atherosclerosis [33] . The other fibrin-bindintegrin signalling involving Ca . Another intriguing ing integrin avb3 is implicated only in fibrin adhesion, but example of integrin-mediated signalling involves SMC not in fibrin clot contraction [33, 76] . Recent data on a5b1 dedifferentiation induced by serum or vitronectin, abunand avb3 integrins indicate that migration of SMCs into dant in serum, but the underlying mechanisms remain fibrin clot may require co-operation of both integrins [77] .
obscure. SMC adhesion to ligands from whole serum or Integrins b1 are implicated in migration of cultured vitronectin via integrin avb1 inhibits SMC contractility. SMCs [22, 66, 78, 79] . Among b1 integrins, only a2b1, Blocking vitronectin with specific antibodies or RGDa5b1 and a7b1 are known to participate in SMC migracontaining peptides diminishes the loss of SMC contractilition and motility [26, 47, 77, 79, 80] . In contrast to b1 ty in cell culture [97] . integrins, avb3 is implicated in SMC migration both in Integrin avb3 has been implicated in SMC proliferation vitro [32, 57, 58, [77] [78] [79] [81] [82] [83] [84] [85] and in vivo [61, 83, 86, 87] . A in response to several stimuli. Integrins avb3 and avb5 blockade of avb3 integrin with cyclic arginine-glycineaugment the mitogenic response to cyclic stretch, mediated aspartic acid (RGD) peptide or RGD mimetic in animal by PDGF [64] . Integrin avb3 enhances proliferative and vascular injury models reduces vessel wall thickening other responses of SMCs to growth factors [82, 85, 98, 99] [61, 83, 86, 87] . Recent investigations have demonstrated and modulates proliferation induced by thrombospondin that this effect may be also related to apoptosis (see [63] . The exact mechanisms of these co-operative effects below).
are not clear, but the physical association between growth While all av-containing integrins interact with vitronecfactor receptors and avb3 in other cell types has been tin and osteopontin and are involved in the adhesion to confirmed, linking the growth factor and avb3 integrin these ECM proteins, only avb3 is implicated in SMC signalling pathways [100, 101] . migration [57, 58, 84] . SMCs, which express avb5 integrin Recently a new wave of research has demonstrated the and do not express avb3, do not migrate to osteopontin importance of cell adhesion in apoptosis. The role for [57, 58] .
avb3 integrin in SMC apoptosis has been studied to provide insight into the mechanisms of restenosis. The dystroglycan isoforms, 100-and 156-kDa, in SM [121] . blockade of avb3 integrin in an animal model of vascular
The 156-kDa isoform is a component of the DGPC [121] . injury reduces intimal thickening, which correlates with Dystrophin expression strongly correlates with the contracabundant apoptosis in injured vessels [102, 103] . The avb3 tile performance of vascular SM both in vivo and in vitro integrin-mediated signalling in apoptosis may be also [123] [124] [125] . Dystrophin is not expressed in cultured SMCs relevant to plaque stability, since blocking of avb3 in the presence of serum [123] , which causes SMC integrin with the peptide products of ECM degradation dedifferentiation. In vivo, dystrophin is found in the may lead to SMC apoptosis and promote plaque rupture. caveolar domain of SMCs outside integrin-containing adherens junctions [126] [127] [128] .
In parallel to the DGPC in SMCs, there is another 3. Dystrophin-glycoprotein complex complex with utrophin [122] , which has been studied to a lesser extent than the DGPC. Utrophin is ubiquitously The dystrophin-glycoprotein complex (DGPC) is exexpressed in cells, including vascular SMCs [125, 129] ; pressed in all types of muscle and is critical for muscle therefore, in contrast to dystrophin, it is not related to function. Mutations in genes encoding DGPC components muscle contraction. The utrophin glycoprotein complex in lead to different forms of muscular dystrophy and car-SM is likely to include 100-kDa a-dystroglycan and bdiomyopathy [104] [105] [106] [107] . The function of the DGPC is to dystroglycan [121, 122] . In cultured aortic SMCs, utrophin provide mechanical stability of the cell membrane during co-localises with a-dystroglycan in the focal adhesions, contraction and protect cells from overstretching [108- containing b1 integrin and the cytoskeletal protein vinculin 111]. The importance of this complex for vascular SM has [130] . Recently a new dystrophin / utrophin-binding protein just started to be unravelled.
aciculin has been characterised in SM [131, 132] . Aciculin The DGPC serves as a link between the basement (also called PGMRP) is expressed predominantly in vascumembrane around muscle cells and the actin filaments lar and visceral SM and to a lesser extent in cardiac muscle (Fig. 2B) . The cell surface receptor for the DGPC is a in humans [132] . Aciculin expression strongly correlates proteoglycan, called a-dystroglycan. It connects other with the differentiated contractile SM phenotype components of the DGPC and laminin and perlecan [132, 133] . Aciculin is likely to be involved in cell adhe- [112, 113] , which are essential ECM components produced sion, as it co-localises with dystrophin, utrophin and aby vascular SMCs [9, 25, 114, 115] . a-Dystroglycan is also dystroglycan in adhesion structures of muscle cells involved in the laminin assembly on cell surfaces followed [130, 131] , but whether PGMRP has structural, signalling by incorporation of other ECM proteins, such as perlecan or other function is unknown. and collagen IV, to form a basement membrane [73, 116] .
The role of a-dystroglycan in SMC adhesion has not An antibody blocking study has revealed that laminin been studied, although the effect of other proteins of the polymerisation by myoblasts is supported much more by DGPC on SM is known. In mdx mice, with the inactivated a-dystroglycan than by b1 or a7 integrins [73] . Studies of dystrophin gene, the mechanical activities in portal vein a-dystroglycan null mice and a-dystroglycan-deficient ES were severely disrupted [134] . Duchenne muscular cells also indicate that a-dystroglycan is indispensable in dystrophy patients (with the mutated dystrophin gene) basement membrane assembly compared with a7b1 integundergoing surgery tend to bleed more during surgery rin [116] [117] [118] .
compared with other patients [135] . Mutations in the a-Dystroglycan is an extracellular protein in contrast to sarcoglycan genes in limb-girdle muscular dystrophy paother integral membrane adhesion receptors. It binds to a tients [107] lead to vascular SM dysfunction and an transmembrane protein b-dystroglycan in complex with increased baseline of myocardial blood flow [136] . In both several other transmembrane proteins, sarcoglycans and groups of patients vascular abnormalities are likely to be sarcospan (reviewed in [104, 119] ). Sarcoglycans contribute caused by weakness of vascular vessel walls and a poor to stability of the whole DGPC [111, 120] and cell memvascular SM vasoconstrictive response due to mutations in brane [110, 111] . Thus, several proteins in the DGPC the dystrophin and sarcoglycan genes. provide a durable link between the ECM and intracellular Recently the importance of DGPC for vascular smooth proteins, whereas this is the function of an adhesion muscle has been demonstrated directly in animal models receptor in other ECM adhesion complexes. For this with mutated DGPC components [120, [137] [138] [139] . Mouse reason, it seems feasible to consider the functioning of the and BIO14.6 hamster animal models deficient in d-sar-DGPC as a whole unit, rather than to consider the function coglycan develop cardiac abnormalities caused by primary of a-dystroglycan alone. vascular dysfunction [137] . The d-sarcoglycan-null mutaThe SM DGPC consists of a-and b-dystroglycans, b-, tion leads to irregularities of the coronary arteries, which d-and e-sarcoglycans, sarcospan and dystrophin [121, 122] .
trigger the onset of myocardial necrosis in mice [137, 140] . The SM DGPC differs from that in striated muscle, which
The b-sarcoglycan-deficient mice develop vascular concontains a different set of sarcoglycans: a, b, g and d strictions in the heart, diaphragm and kidneys, which result [121, 122] . There are two differently glycosylated ain muscular dystrophy and cardiomyopathy with focal areas of necrosis, associated with the disrupted DGPC in artery, syndecans-2 and -4 are enriched in the medial layer. all muscle types [120] . Thus, mutations in b-and d-
The arterial medial layer contains most of syndecan-1 and sarcoglycans in mice perturb vascular function, which in syndecan-4 mRNA. In contrast to syndecan-2 and -3, turn initiates cardiomyopathy.
syndecan-1 and -4 are increased after arterial injury in animal models [156, 157] . Since syndecans participate in the ECM assembly, they may be involved in the ECM 4. Syndecans repair after vascular injury. Syndecan-1, -2 and -4 are expressed in cultured vascular SMCs [156, 158, 159] . ExSyndecans are members of a proteoglycan family of pression of syndecan-1 and -4 varies in cultured SMCs in adhesion transmembrane receptors with the glycosaminoresponse to serum and growth factors, while syndecan-2 is glycan chains covalently attached to the extracellular part expressed constitutively. The significance of syndecans in of the receptor (reviewed in [141, 142] ). There are four SMC adhesion and migration has not been studied. known mammalian syndecans. Syndecans bind to a variety Since syndecans bind to growth factors, lipoprotein of ECM proteins ( Fig. 2A) , cell adhesion molecules, lipases and components of the blood-coagulation cascade, growth factors, lipoproteins, lipoprotein lipases and comthey may have pleiotropic effects on SMC functioning. ponents of the blood-coagulation cascade. To date, all Thrombin treatment of vascular SMCs augments expresknown syndecans interact with their ligands via polysacsion of syndecan-1, exhibiting high affinity antithrombin charide chains, although syndecan-4 may also support cell III-binding activity [160] . Therefore, SMCs could play an adhesion by a protein core [143] . These receptors play important role in controlling local thrombus formation important roles in cell-ECM and cell-cell adhesion and subsequent to vascular injury, via a feedback mechanism migration (reviewed in [141, 142, 144] ). Syndecans are that involves thrombin-induced stimulation of SMC surthought to be co-receptors providing additional sites for face syndecan-1 expression, which generates anticoagulant ECM ligands in order to increase the strength of cell activity via binding of antithrombin III, an inhibitor of adhesion ( Fig. 2A) .
thrombin activity [160] . All syndecans bind to PDZ-containing proteins (the PDZ domain is called after proteins PSD-95 / DlgA / ZO-1, where it was originally found) linking syndecans to the 5. Cell adhesion molecules cytoskeleton [145] . Syndecan-4 is consistently found in focal adhesions of several cell types, including SMCs Cell adhesion molecules belong to the immunoglobulin [146] . Recent data have implicated syndecans, and family of cell-cell adhesion receptors with a transmemsyndecan-4 in particular, in the assembly of focal adhebrane domain. There is not much known about the link sions and actin cytoskeleton [147] [148] [149] [150] [151] [152] . Similar to integbetween these receptors and the actin cytoskeleton. Interrins, syndecans are involved both in cytoskeleton and cellular cell adhesion molecule (ICAM-1) is known to ECM assembly. Syndecan-2 affects the assembly of interact with the cytoskeletal proteins a-actinin and ezrin laminin and fibronectin fibrils and can override the func- [161, 162] . Two adhesion molecules VCAM-1 and ICAM-1 tion of activated integrins in ECM assembly [153] . Growhave been detected in vascular SM. VCAM-1 is a countering evidence suggests that syndecans are involved in cell receptor for the a4b1, a9b1, a4b7 and aDb2 integrins, signalling. Syndecan-4-mediated signalling involves propresent on lymphocytes and monocytes [54, 163, 164] . tein kinase PKCa and phosphatidylinositol-4,5-biphos-ICAM-1 interacts with b2 integrins, present on neutrophate (PIP2) via direct binding of syndecan-4 to PKCa phils, monocytes and lymphocytes [163, 165] . ICAM-1 also and PIP2 (reviewed in [145, 154] ).
binds to fibrinogen and, thereby, can participate in ECMAn intriguing feature of syndecans is their involvement cell interactions [166] [167] [168] (Fig. 2C) . The expression of in other cellular functions, such as proliferation, growth VCAM-1 and ICAM-1 in vasculature and their potential factor signalling and lipid metabolism (reviewed in roles in the development of atherosclerosis were thorough-[141, 142, 144] ). Syndecans bind to the heparin-binding ly reviewed recently [169] . growth factors, such as basic FGF, VEFG and EGF, and VCAM-1 is found in human foetal aortic SMCs expressprovide secondary binding sites for them on the cell ing a4b1 integrin (see above), but not in the normal adult surface. Therefore, syndecans may be involved in mediataortic media [38] . VCAM-1 expression in SMCs in ing growth factor-induced responses in vascular SM.
atherosclerotic lesions is well-documented [170] [171] [172] . Syndecans, in particular syndecan-1, may also participate VCAM-1 is also upregulated in SMCs after vascular injury in lipid metabolism, as syndecan-1 may mediate LDL and co-expressed with monocyte chemotactic protein receptor-independent clearance of lipoproteins via binding (MCP)-1 in SMCs within 4 h of injury [173] . Macrophage to lipoprotein lipase, an enzyme involved in triglyceride infiltration occurs in parallel with the expression of catabolism [155] .
VCAM-1 and MCP-1; these inflammatory cells are present All four known syndecans are expressed in normal on the lumenal surface of injured vessels during intimal arterial SMCs [156] . Syndecan-1 is enriched in the whole lesion formation [173] . Similar to VCAM-1, ICAM-1 is expressed in atherosclerotic SMCs, but not in normal venous SM compared to arterial SM [194] . In rat aorta contractile SMCs [172] . ICAM-1 is induced in SMCs of N-cadherin is found in a population of SMCs adjacent to saphenous vein after culturing with serum or TNF-a ex ECs [188] . An anti-N-cadherin antibody inhibits adhesion 21 vivo [174] . ICAM-1 expression in vitro is phenotypebetween SMCs and ECs in a Ca -dependent manner, dependent and can only be induced in SMCs with de- indicating that N-cadherin may mediate EC-SMC interaccreased or modulated myofilament volume [175] . In cultions in vivo [188] . However, as ECs are separated from tured SMCs expression of VCAM-1 and ICAM-1 can be the SM layer by the basement membrane, they can only be induced by cytokines [170, [176] [177] [178] . Increased surface in contact with SMCs after vascular injury and in ulcerated expression of VCAM-1 and ICAM-1 on SMCs leads to atherosclerotic plaques. augmented adhesion of a4 integrin-positive lymphocytes T-Cadherin was originally identified as a novel lipopand b2 integrin-containing monocytes [178, 179] . Since the rotein-binding protein in a membrane fraction of aortic expression of VCAM-1 and ICAM-1 can be induced by SMCs [190] . T-Cadherin amounts are significantly higher cytokines in SMCs, these adhesion molecules are likely to in fatty streaks and aortic fibrous plaque tissue compared play important roles in the pathophysiology of inflammato normal aorta [195] . The expression of T-cadherin is high tory and immune processes in atherosclerosis by enabling in vascular SMCs, but reduced by 75% in culture leukocyte trafficking within atherosclerotic vascular tissue. [194, 195] . T-Cadherin expression is cell density dependent ICAM-1 expression of SMCs affects not only adhesion with the highest level in confluent cells and is downreguof monocytes, but also expression of tissue factor and lated by serum and growth factors [196, 197] . procoagulant activity of monocytes [180] . Thereby, the In contrast to other cadherins, E-cadherin is not found in interactions between monocytes and ICAM-1-expressing normal vascular SMCs, but the majority of atherosclerotic SMCs within atherosclerotic plaques would increase the lesions contain cells positively stained for E-cadherin thrombogenic properties of the plaques; in the case of [198] . In atherosclerotic intima, E-cadherin is expressed by plaque rupture it would lead to thrombus formation and intimal cells showing varying degrees of transformation SMC adhesion to fibrinogen via integrins and ICAM-1.
into foam cells [198] . After balloon injury an increased Since ICAM-1 participates in cell signalling in other cell level of E-cadherin coincides with the initiation of SMC types, SMC adhesion to fibrinogen via ICAM-1 may lead proliferation, whereas the levels of R-and T-cadherins to other events. ICAM-1 ligation induces VCAM-1 exprestemporarily decrease [192] . sion in ECs [181] . Interaction between ICAM-1 and Since normal contractile SMCs are surrounded by ECM, fibrinogen results in proliferation and increased cell surviv-SMC adhesion to ECM is predominant in vascular SM, al of non-SMCs [182, 183] . Ligation of fibrinogen to although cell-cell contacts may increase during tissue ICAM-1 on the cell surface of ECs stimulates the tyrosine remodelling or in vascular injury, when the basement phosphorylation of several proteins involved in signalling membranes, underlying ECs and around SMCs, are de- [183, 184] . As mentioned above, fibrinogen is abundant in graded or damaged. Cadherin expression in adult vascular the intima of atherosclerotic aorta, where SMCs express SMCs seems to be to some extent redundant, however, in ICAM-1. The effect of fibrinogen on SMCs expressing other cell types E-and N-cadherins are implicated in ICAM-1 remains to be investigated.
contact inhibition of growth [199, 200] . Furthermore, Ecadherin is also implicated in a physiological pathway required for cell survival [201] . Therefore, the significance 6. Cadherins of cadherin interactions in normal and especially pathological conditions, such as vascular injury with All cadherins, except T-cadherin, belong to a family of induced ECM rearrangement, SMC migration and prolifer- 21 transmembrane Ca -dependent homophilic cell-cell ation, requires further investigation. adhesion receptors. T-Cadherin is anchored to the cell membrane via glycosylphosphatidylinositol. N-and Rcadherins can also support heterophilic adhesion [185] .
7. Closing remarks Cadherin homodimers form a 'zipper' structure at the intercellular contact zone on the cell surface [186] . These
The data, summarised in this review, demonstrate the receptors bind to the cytoplasmic plaque proteins catenins, fundamental importance of cell adhesion receptors in the which provide a link with vinculin and the actin cytophysiology of vascular SM. SMCs use a range of adhesion skeleton. Cadherins are involved in signalling mediated by receptors involved in diverse biological functions of SMCs b-catenin (reviewed in [186, 187] ). Expression of N-, Runder normal and pathological conditions, such as vascular and T-cadherins has been reported in normal vascular injury and atherosclerosis (summarised in Table 2 ). SMCs [188] [189] [190] [191] [192] . Cadherin 6B, expressed in chicken A growing body of evidence indicates that cell adhesion, aorta, is characterised as a specific marker for differenspreading, migration and ECM assembly involve several tiated SM phenotype [193] .
types of adhesion receptors. Some types of adhesion N-Cadherin is expressed at a higher level in human receptors can regulate other types and / or may require [26, 32, 65] integrin in neointima enables SMC proliferation between SMCs and VCAM-1-expressing a5b1 and a7b1 participate and migration [65, 66] . a5b1 is induced at the ECs [38, 54] . a5b1 may cause vessel in the assembly of FN and luminal surface of the neointima and participates narrowing during the progression of LN matrices, respectively in the incorporation of plasma FN into ECM to atherosclerosis due to FB contraction [33] [41, 73] repair blood vessel wall [41] . a5b1 may be involved avb3 enhances SMC proliferative and other in FB clot contraction on the damaged surface of the responses to TSP and growth factors [82, 85, 98, 99 ] blood vessel wall [33] . a1b1 may be involved in COL avb3 may cause SMC apoptosis, when blocked remodelling after vascular injury repair [30] avb1 inhibits with the peptide products of ECM degradation, SMC contractility in SMC exposed to serum [97] and promote plaque rupture Upregulated avb3 is involved in SMC migration [61, 83, 86, 87] [73, 116, 117] Exposure to serum abolishes DGPC may be involved in dystrophin expression [123] SM contractility [123, 124] 
Syndecans
All four syndecans are Syndecan-1 and -4 are upregulated [156, 157] and Syndecan-1 may be involved in triglyceride expressed [156] may be involved in the ECM assembly and repair catabolism via binding to lipoprotein after vascular injury. In SMCs exposed to thrombin, lipase [155] syndecan-1 expression increases anticoagulant activity [160] CAMs VCAM-1 and ICAM-1 are VCAM-1 is present in parallel with macrophage VCAM-1 and ICAM-1 are expressed [170-172] not found [38, 172] infiltration to enable macrophage and participate in inflammatory and immune cell trafficking [173] trafficking [178, 179] within atherosclerotic tissue SMC ICAM-1 induces procoagulant activity of monocytes and increases thrombogenic properties of atherosclerotic plaques [180] Cadherins N-, R-and T-cadherins and E-Cadherin expression increases, E-Cadherin is expressed [198] cadherin 6B are expressed the levels of R-and T-cadherin T-cadherin is markedly upregulated [195] [188] [189] [190] [191] [192] [193] decrease [192] Lipoprotein-binding T-cadherin may be involved in lipid metabolism
Abbreviations as in Table 1. co-operation with other types of adhesion receptors. Some type has not been identified, a-dystroglycan is indisintegrins can regulate expression and activity of other pensable for the laminin assembly. integrins [45, 67] and N-cadherin [202] or require co-2. Integrins a1b1 and a5b1 are likely to participate in operation with other integrins [77] and syndecans collagen remodelling and fibrin clot contraction, respec- [150, 152, 153] . Syndecans are known to affect both integtively, after vascular injury. ECM remodelling activities rins and cadherins [203] . ICAM-1 ligation induces expresof these integrins within the blood vessel wall may sion of the other adhesion receptor VCAM-1 [181] . Such cause blood vessel narrowing. interactions between adhesion receptors in SM have not 3. Although integrin avb3 is expressed both in normal been studied; nevertheless they may be significant for the and diseased blood vessels, some ECM ligands of avb3 co-ordinated cell-cell and cell-ECM adhesion during (thrombospondin, vitronectin, osteopontin, fibrin and vascular injury and / or in development of vascular disfibrinogen) are found only in injured or diseased blood eases.
vessels. Furthermore, this integrin is also involved in In conclusion, the following points should be emphasignalling. For these reasons, SMC adhesion via avb3 sised may have a profound effect on many other SMC functions, such as migration, proliferation and apoptosis 1. Laminin, found in the basement membrane around in vascular injury. Blocking of the integrin avb3 with SMCs, plays the pivotal role in SMC differentiation.
products of degradation of ECM proteins may contribAdhesion receptors to laminin, integrins a1b1 and ute to apoptotic process within the atherosclerotic tissue a7b1 and a-dystroglycan in the DGPC, are expressed and affect plaque stability. The adhesion and signalling only in contractile SMCs. While the adhesion receptor properties of avb3 integrin ensure its unique role in responsible for maintaining the SM contractile phenopathophysiological conditions. It is becoming clear that cell adhesion is a complex functioning of vascular SM in norm and disease. 
